# Sanofi timeline entity: /record/sanofi.md id: ent_sanofi Sanofi's timeline holds 70 claims from 2001 to 2025: 54 money & deals, 16 other. 11 are undated. The latest took effect on December 31, 2025. Kinds: People 0 (/timelines/sanofi.md?kind=people) · Money & deals 54 (/timelines/sanofi.md?kind=money) · Products 0 (/timelines/sanofi.md?kind=products) · Models 0 (/timelines/sanofi.md?kind=models) · Other 16 (/timelines/sanofi.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 2001 - 2001-01-08 to 2004-08-24 | other | registrant_name | SANOFI SYNTHELABO SA | superseded | [clm_B16C8D81398B](/claim/clm_B16C8D81398B.md) ## 2004 - 2004-08-30 to 2011-05-09 | other | registrant_name | SANOFI-AVENTIS | superseded | [clm_6FE72762BC43](/claim/clm_6FE72762BC43.md) ## 2009 - 2009-04-27 | other | x_username | sanofi | unverified | [clm_1E1B737CB8C1](/claim/clm_1E1B737CB8C1.md) ## 2010 - 2010-08-25 | other | x_username | SanofiUS | unverified | [clm_77FE24C35D37](/claim/clm_77FE24C35D37.md) ## 2011 - 2011-05-09 | other | registrant_name | Sanofi | valid | [clm_CC86206FE0B6](/claim/clm_CC86206FE0B6.md) ## 2014 - 2014-12-31 to 2015-12-31 | money | total_equity | 56,268,000,000 euro | superseded | [clm_7E56B9C44815](/claim/clm_7E56B9C44815.md) ## 2015 - 2015-12-31 to 2016-12-31 | money | net_income | 4,388,000,000 euro | superseded | [clm_0AC80B6E5277](/claim/clm_0AC80B6E5277.md) - 2015-12-31 to 2016-12-31 | money | operating_income | 5,624,000,000 euro | superseded | [clm_9A75CFABD57F](/claim/clm_9A75CFABD57F.md) - 2015-12-31 to 2016-12-31 | money | total_assets | 102,321,000,000 euro | superseded | [clm_3C3EC521E0D4](/claim/clm_3C3EC521E0D4.md) - 2015-12-31 to 2016-12-31 | money | total_equity | 58,210,000,000 euro | superseded | [clm_05D9D24F8147](/claim/clm_05D9D24F8147.md) ## 2016 - 2016-12-31 to 2017-12-31 | money | net_income | 4,800,000,000 euro | superseded | [clm_95BE055DC4D9](/claim/clm_95BE055DC4D9.md) - 2016-12-31 to 2017-12-31 | money | operating_income | 6,534,000,000 euro | superseded | [clm_0165A463D67B](/claim/clm_0165A463D67B.md) - 2016-12-31 to 2017-12-31 | money | total_assets | 104,672,000,000 euro | superseded | [clm_AD5E81D9A13F](/claim/clm_AD5E81D9A13F.md) - 2016-12-31 to 2017-12-31 | money | total_equity | 57,724,000,000 euro | superseded | [clm_076452FBA031](/claim/clm_076452FBA031.md) ## 2017 - 2017-12-31 to 2018-12-31 | money | net_income | 8,555,000,000 euro | superseded | [clm_D197426EB600](/claim/clm_D197426EB600.md) - 2017-12-31 to 2018-12-31 | money | operating_income | 5,803,000,000 euro | superseded | [clm_6BBC95FC9D5A](/claim/clm_6BBC95FC9D5A.md) - 2017-12-31 to 2018-12-31 | money | shares_outstanding | 1,254,019,904 shares | superseded | [clm_71654A36B3AF](/claim/clm_71654A36B3AF.md) - 2017-12-31 to 2018-12-31 | money | total_assets | 99,826,000,000 euro | superseded | [clm_63D1AD427E24](/claim/clm_63D1AD427E24.md) - 2017-12-31 to 2018-12-31 | money | total_equity | 58,258,000,000 euro | superseded | [clm_B496EA6FC6B8](/claim/clm_B496EA6FC6B8.md) ## 2018 - 2018-12-31 to 2019-12-31 | money | net_income | 4,410,000,000 euro | superseded | [clm_0FF175FD232C](/claim/clm_0FF175FD232C.md) - 2018-12-31 to 2019-12-31 | money | operating_income | 4,676,000,000 euro | superseded | [clm_B6E82A12DC04](/claim/clm_B6E82A12DC04.md) - 2018-12-31 to 2019-12-31 | money | shares_outstanding | 1,245,454,385 shares | superseded | [clm_F4BBE4DF28FC](/claim/clm_F4BBE4DF28FC.md) - 2018-12-31 to 2019-12-31 | money | total_assets | 111,408,000,000 euro | superseded | [clm_CB6CF5B7AD8C](/claim/clm_CB6CF5B7AD8C.md) - 2018-12-31 to 2019-12-31 | money | total_equity | 59,035,000,000 euro | superseded | [clm_0BAD9929DA5B](/claim/clm_0BAD9929DA5B.md) ## 2019 - 2019-12-31 to 2020-12-31 | money | net_income | 2,837,000,000 euro | superseded | [clm_7015A64270D6](/claim/clm_7015A64270D6.md) - 2019-12-31 to 2020-12-31 | money | operating_income | 3,125,000,000 euro | superseded | [clm_52B568F84169](/claim/clm_52B568F84169.md) - 2019-12-31 to 2020-12-31 | money | shares_outstanding | 1,253,826,630 shares | superseded | [clm_F63D688C817C](/claim/clm_F63D688C817C.md) - 2019-12-31 to 2020-12-31 | money | total_assets | 112,736,000,000 euro | superseded | [clm_7C3AF0234FFE](/claim/clm_7C3AF0234FFE.md) - 2019-12-31 to 2020-12-31 | money | total_equity | 59,108,000,000 euro | superseded | [clm_BE091B89DE16](/claim/clm_BE091B89DE16.md) ## 2020 - 2020-12-31 to 2021-12-31 | money | net_income | 12,350,000,000 euro | superseded | [clm_0904A5EB7F48](/claim/clm_0904A5EB7F48.md) - 2020-12-31 to 2021-12-31 | money | operating_income | 14,141,000,000 euro | superseded | [clm_82ED7B403D30](/claim/clm_82ED7B403D30.md) - 2020-12-31 to 2021-12-31 | money | shares_outstanding | 1,250,690,553 shares | superseded | [clm_042B61EE0086](/claim/clm_042B61EE0086.md) - 2020-12-31 to 2021-12-31 | money | total_assets | 114,529,000,000 euro | superseded | [clm_E38FFF08217D](/claim/clm_E38FFF08217D.md) - 2020-12-31 to 2021-12-31 | money | total_equity | 63,147,000,000 euro | superseded | [clm_996815FA130E](/claim/clm_996815FA130E.md) ## 2021 - 2021-12-31 to 2022-12-31 | money | net_income | 6,279,000,000 euro | superseded | [clm_AB77E8D57250](/claim/clm_AB77E8D57250.md) - 2021-12-31 to 2022-12-31 | money | operating_income | 8,126,000,000 euro | superseded | [clm_CC3F78AEF426](/claim/clm_CC3F78AEF426.md) - 2021-12-31 to 2022-12-31 | money | shares_outstanding | 1,263,560,695 shares | superseded | [clm_53A5A57A2B90](/claim/clm_53A5A57A2B90.md) - 2021-12-31 to 2022-12-31 | money | total_assets | 120,242,000,000 euro | superseded | [clm_9CBE3B0D9AFC](/claim/clm_9CBE3B0D9AFC.md) - 2021-12-31 to 2022-12-31 | money | total_equity | 69,031,000,000 euro | superseded | [clm_1D7CB2803602](/claim/clm_1D7CB2803602.md) ## 2022 - 2022-12-31 to 2023-12-31 | money | net_income | 8,484,000,000 euro | superseded | [clm_801470DA2EB3](/claim/clm_801470DA2EB3.md) - 2022-12-31 to 2023-12-31 | money | operating_income | 10,656,000,000 euro | superseded | [clm_D0BA9E7A3008](/claim/clm_D0BA9E7A3008.md) - 2022-12-31 to 2023-12-31 | money | shares_outstanding | 1,260,835,732 shares | superseded | [clm_AF0CA69A1600](/claim/clm_AF0CA69A1600.md) - 2022-12-31 to 2023-12-31 | money | total_assets | 126,722,000,000 euro | superseded | [clm_C5B81340FE0F](/claim/clm_C5B81340FE0F.md) - 2022-12-31 to 2023-12-31 | money | total_equity | 75,152,000,000 euro | superseded | [clm_656DD677972E](/claim/clm_656DD677972E.md) ## 2023 - 2023-12-31 to 2024-12-31 | money | net_income | 5,436,000,000 euro | superseded | [clm_B67C5E6FE8F4](/claim/clm_B67C5E6FE8F4.md) - 2023-12-31 to 2024-12-31 | money | operating_income | 7,875,000,000 euro | superseded | [clm_123AB0DABDC4](/claim/clm_123AB0DABDC4.md) - 2023-12-31 to 2024-12-31 | money | shares_outstanding | 1,264,799,969 shares | superseded | [clm_22EF04FFDFE1](/claim/clm_22EF04FFDFE1.md) - 2023-12-31 to 2024-12-31 | money | total_assets | 126,464,000,000 euro | superseded | [clm_847718467FF9](/claim/clm_847718467FF9.md) - 2023-12-31 to 2024-12-31 | money | total_equity | 74,353,000,000 euro | superseded | [clm_74870A5769C1](/claim/clm_74870A5769C1.md) ## 2024 - 2024-12-31 to 2025-12-31 | money | net_income | 5,618,000,000 euro | superseded | [clm_3C83F22DA25C](/claim/clm_3C83F22DA25C.md) - 2024-12-31 to 2025-12-31 | money | operating_income | 7,252,000,000 euro | superseded | [clm_2A73031627AE](/claim/clm_2A73031627AE.md) - 2024-12-31 to 2025-12-31 | money | shares_outstanding | 1,263,122,721 shares | superseded | [clm_1EA191887854](/claim/clm_1EA191887854.md) - 2024-12-31 to 2025-12-31 | money | total_assets | 132,798,000,000 euro | superseded | [clm_C05467B0F350](/claim/clm_C05467B0F350.md) - 2024-12-31 to 2025-12-31 | money | total_equity | 77,857,000,000 euro | superseded | [clm_FDB42C5F0980](/claim/clm_FDB42C5F0980.md) ## 2025 - 2025-12-31 | money | net_income | 7,851,000,000 euro | valid | [clm_19BBD676652F](/claim/clm_19BBD676652F.md) - 2025-12-31 | money | operating_income | 6,344,000,000 euro | valid | [clm_8921516E4AAC](/claim/clm_8921516E4AAC.md) - 2025-12-31 | money | shares_outstanding | 1,219,427,096 shares | valid | [clm_D84AA173DA36](/claim/clm_D84AA173DA36.md) - 2025-12-31 | money | total_assets | 126,805,000,000 euro | valid | [clm_AFEF894CA05B](/claim/clm_AFEF894CA05B.md) - 2025-12-31 | money | total_equity | 71,710,000,000 euro | valid | [clm_4096DE18ACC6](/claim/clm_4096DE18ACC6.md) ## undated - undated | other | cik | 0001121404 | valid | [clm_540F985CF047](/claim/clm_540F985CF047.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_E05D0095C092](/claim/clm_E05D0095C092.md) - undated | other | headquarters | Paris | valid | [clm_5F6E41EC6A71](/claim/clm_5F6E41EC6A71.md) - undated | other | listed_on | OTC | valid | [clm_24748DC940EB](/claim/clm_24748DC940EB.md) - undated | other | listed_on | Nasdaq | valid | [clm_BADB19E46B27](/claim/clm_BADB19E46B27.md) - undated | other | sic_industry | Pharmaceutical Preparations (2834) | valid | [clm_033381EF4CA7](/claim/clm_033381EF4CA7.md) - undated | other | state_of_incorporation | I0 | valid | [clm_A379C95A5046](/claim/clm_A379C95A5046.md) - undated | other | ticker | SNY | valid | [clm_09418C806EE2](/claim/clm_09418C806EE2.md) - undated | other | ticker | SNYNF | valid | [clm_CA202958CDCB](/claim/clm_CA202958CDCB.md) - undated | other | website | https://www.sanofi.com/ | unverified | [clm_CCE7CF60315C](/claim/clm_CCE7CF60315C.md) - undated | other | website | https://www.sanofi.us/ | unverified | [clm_ED906BDD14FA](/claim/clm_ED906BDD14FA.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.